By using Nutlin-3a, a small-molecule inhibitor of HDM2, the authors demonstrate that p53 activity can be restored in MCC cell lines, leading to cell cycle arrest or apoptosis of MCC cell lines [99,100]. The gene discussed is TP53; the disease is Merkel cell skin cancer.